EUVIMEDEUVIMED entdecken
Crossref

Early Antiplatelet Resumption and the Risks of Major Bleeding After Intracerebral Hemorrhage

Chi-Hung Liu iD, Yi-Ling Wu iD, Chih-Cheng Hsu iD, Tsong-Hai Lee iD

Stroke · 2023

DOI: 10.1161/strokeaha.122.040500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2023. Verfasst von Chi-Hung Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Linkou Chang Gung Memorial Hospital, and College of Medicine, Chang Gung University, Taoyuan, Taiwan (C.-H.L., T.-H.L.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Stroke, Stroke. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The appropriate timing of resuming antithrombotic therapy after intracerebral hemorrhage (ICH) remains unclear. The aim of this study was to compare the risks of major bleeding between early and late antiplatelet resumption in ICH survivors.

Methods

Between 2008 and 2017, ICH patients were available in the National Health Insurance Research Database. Patients with a medication possession ratio of antiplatelet treatment ≥50% before ICH and after antiplatelet resumption were screened. We excluded patients with atrial fibrillation, heart failure, under anticoagulant or hemodialysis treatment, and developed cerebrovascular events or died before antiplatelet resumption. Finally, 1584 eligible patients were divided into EARLY (≤30 days) and LATE groups (31–365 days after the index ICH) based on the timing of antiplatelet resumption. Patients were followed until the occurrence of a clinical outcome, end of 1-year follow-up, death, or until December 31, 2018. The primary outcome was recurrent ICH. The secondary outcomes included all-cause mortality, major hemorrhagic events, major occlusive vascular events, and ischemic stroke. Cox proportional hazard model after matching was used for comparison between the 2 groups.

Results

Both the EARLY and LATE groups had a similar risk of 1-year recurrent ICH (EARLY versus LATE: 3.12% versus 3.27%; adjusted hazard ratio [AHR], 0.967 [95% CI, 0.522–1.791]) after matching. Both groups also had a similar risk of each secondary outcome at 1-year follow-up. Subgroup analyses disclosed early antiplatelet resumption in the patients without prior cerebrovascular disease were associated with lower risks of all-cause mortality (AHR, 0.199 [95% CI, 0.054–0.739]) and major hemorrhagic events (AHR, 0.090 [95% CI, 0.010–0.797]), while early antiplatelet resumption in the patients with chronic kidney disease were associated with a lower risk of ischemic stroke (AHR, 0.065 [95% CI, 0.012–0.364]).

Conclusions

Early resumption of antiplatelet was as safe as delayed antiplatelet resumption in ICH patients. Besides, those without prior cerebrovascular disease or with chronic kidney disease may benefit more from early antiplatelet resumption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationIschemic StrokeStrokeHumansCerebral HemorrhageAnticoagulantsRisk Factors

Stichwörter der Autor:innen

antiplateletantiplatelet resumptionintracerebral hemorrhageischemic strokemajor bleeding

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Neurology, Linkou Chang Gung Memorial Hospital, and College of Medicine, Chang Gung University, Taoyuan, Taiwan (C.-H.L., T.-H.L.).
  • Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei (C.-H.L.).
  • Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan (Y.-L.W., C.-C. H.).
  • National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Department of Family Medicine, Min-Sheng General Hospital, Taoyuan, and Department of Health Services Administration, Chi…

ORCID-Profile: Chi-Hung Liu, Yi-Ling Wu, Chih-Cheng Hsu, Tsong-Hai Lee

Förderung

  • Chang Gung Memorial Hospital

Zitieren

APA

Liu, C. H., Wu, Y. L., Hsu, C. C., & Lee, T. H. (2023). Early Antiplatelet Resumption and the Risks of Major Bleeding After Intracerebral Hemorrhage. Stroke. https://doi.org/10.1161/strokeaha.122.040500

Vancouver

Liu CH, Wu YL, Hsu CC, Lee TH. Early Antiplatelet Resumption and the Risks of Major Bleeding After Intracerebral Hemorrhage. Stroke. 2023. doi:10.1161/strokeaha.122.040500

BibTeX
@article{Liu2023,
  author = {Liu, Chi-Hung and Wu, Yi-Ling and Hsu, Chih-Cheng and Lee, Tsong-Hai},
  title = {Early Antiplatelet Resumption and the Risks of Major Bleeding After Intracerebral Hemorrhage},
  journal = {Stroke},
  year = {2023},
  doi = {10.1161/strokeaha.122.040500}
}
Kostenlos starten →